'
Home / About / Einstein Care Partners ACO / Medicare Shared Savings ACO Public Reporting

Medicare Shared Savings ACO Public Reporting

Columns Layout = 2

ACO Name and Location

Einstein Care Partners, LLC
3300 Henry Avenue
Falls 2 Suite 601
Philadelphia, Pennsylvania 19129-1121

ACO Primary Contact

Primary Contact Name  Shivanandh Chandrasekaran
Primary Contact Phone Number 215-774-4134
Primary Contact Email Address chandras@einstein.edu

 

Organizational Information

ACO Participants:

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Fornance Physician Services Inc N
Einstein Practice Plan Inc N
Einstein Community Health Associates, Inc        N

 

ACO Governing Body:

Member Member's Voting Power Membership Type ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Nicholas, MD

Angela

Co-Chair

1

ACO Participant Representative

Fornance Physician Services

Sivak, MD Steven Co-Chair 1 ACO Participant Representative Einstein Practice Plan
Behme, MD Matthew Member 1 ACO Participant Representative Einstein Practice Plan
Datner, MD Elizabeth Member 1 ACO Participant Representative
Einstein Practice Plan
Dubois Ruth Member 1 Medicare Beneficiary Representative
 

Duffy

Beth

Member

1

ACO Participant Representative

Fornace Physician Services

Gulati, MD
Rohit
Member
1 ACO Participant Representative
Einstein Practice Plan
James Dixie Member 1 Other Albert Einstein Medical Center
Johnson, MD Ahashta Member 1 ACO Participant Representative Fornance Physician Services
Leighton, MD John Member 1 ACO Participant Representative Einstein Practice Plan
Levitan Ken Member 1 Other Einstein Healthcare Network
Rose, MD Gina Member 1 ACO Participant Representative Fornance Physician Services
Scaven, MD Christopher Member 1 ACO Participant Representative Einstein Community Health Associates

Chandrasekaran, MD

Shivanandh

Member

0

Other

Einstein Care Partners, LLC

Key ACO Clinical and Administrative Leadership:

Shivanandh Chandrasekaran, MD

ACO Executive

Shivanandh Chandrasekaran, MD

Medical Director

Marianne DeJesus

Compliance Officer

Shivanandh Chandrasekaran, MD

Quality Assurance/Improvement Officer

 

Associated Committees and Committee Leadership:

Committee Name

Committee Leader Name and Position

Clinical Performance and Integration Committee

Jason Aronovitz, DO (Co-Chairperson) and Shivanandh Chandrasekaran, MD (Co-Chairperson)

Membership and Nominating Committee

Angela Nicholas, MD (Co-Chairperson) and Steven Sivak, MD (Co-Chairperson)

Types of ACO Participants, or Combinations of Participants, That Formed The ACO:

  • ACO professionals in a group practice arrangement
  • Networks of individual practices of ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses

Third Agreement Period

  • Performance Year 2020: $6,273,203

Second Agreement Period

  • Performance Year 2019: $0

First Agreement Period

  • Performance Year 2018: $1,905,474

Shared Savings Distribution

Third Agreement Period

Performance Year 2020

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 10%
  • Proportion of distribution to ACO participants: 80%

Second Agreement Period

Performance Year 2019

  • Proportion invested in infrastructure: N/A
  • Proportion invested in redesigned care processes/resources: N/A
  • Proportion of distribution to ACO participants: N/A

First Agreement Period

Performance Year 2019

  • Proportion invested in infrastructure: 10%
  • Proportion invested in redesigned care processes/resources: 10%
  • Proportion of distribution to ACO participants: 80%

Quality Performance Results

2020 Quality Performance Results

ACO # Measure Name Rate  ACO Mean
ACO-43 Ambulatory Sensitive Condition Acute Composite (AHRQ Prevention Quality Indicator (PQI #91)
 0.79  0.95
ACO-13
Falls: Screening for Future Fall Risk
86.27 84.97
ACO-14
Preventative Care and Screening: Influenza Immunization
60.30 76.03
ACO-17
Preventative Care and Screening: Tobacco Use: Screening and Cessation Intervention
79.10 81.67
ACO-18
Preventative Care and Screening: Screening for Depression and Follow-up Plan
74.37 71.46
ACO-19
Colorectal Cancer Screening
61.46 72.59
ACO-20
Breast Cancer Screening
66.94 74.05
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease 87.70 83.37
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
18.86 14.70
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
63.01 72.87

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized, All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019 (COVID-19) public health emergency (PHE) on these measures.

For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov.

ACO Participation Waiver:

The following information describes each arrangement for which our ACO seeks protection under the ACO Participation Waiver, including any material amendment or modification to a disclosed arrangement.

  • Parties to the arrangement: ACO and ACO Participants listed above
  • Date of arrangement: January 1, 2018
  • Items, services, goods, or facility provided: ACO provides administrative and analytic support to ACO Participants.
  • Date and nature of any amendments to the arrangement, if applicable: N/A

Download this information in a document (PDF) here.

© 2021 Einstein Healthcare Network. All rights reserved.